Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety, Efficacy and Acceptability of Flavocoxid (Limbrel) Compared With Naproxen in Subjects With Osteoarthritis of the Knee. A Pilot Study

NCT00303017 is registered in ClinicalTrials.gov with Primus Pharmaceuticals as lead sponsor.

NCT NCT00303017
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00303017 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety, Efficacy and Acceptability of Flavocoxid (Limbrel) Compared With Naproxen in Subjects With Osteoarthritis of the Knee. A Pilot Study
Lead sponsor
Primus Pharmaceuticals
Phase
Not applicable
Overall status
Completed
Start date
March 31, 2006
Completion date
September 30, 2006
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis